| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 736.0 | 1036.5 | 874.5 |
| Other income | 25.3 | 22.2 | 17.7 |
| Total income | 761.3 | 1058.7 | 892.2 |
| Profit before exceptional items & tax | -5.7 | 202.0 | 101.3 |
| Exceptional items | -13.5 | -6.0 | 0.0 |
| Profit before tax | -19.2 | 196.0 | 101.3 |
| Net profit | -9.0 | 147.9 | 86.7 |
| Operating margin | -2.5% | 18.5% | 11.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -15.80% |
|---|---|
| Operating profit, year on year | -149.70% |
| Operating profit, quarter on quarter | -127.30% |
NSE results filing, NSE: SYNGENE. Figures extracted from the filing.
Syngene International Ltd: key numbers
- Share price
- ₹378.70
- Market cap
- ₹15,287 Cr
- Revenue (annual)
- ₹3,739 Cr
- Net profit (annual)
- ₹316.7 Cr
- P/E (TTM)
- 69.2×Sector 50.4×
- Promoter holding
- 52.59%-0.09% QoQ
- FII holding
- 11.82%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Syngene International Ltd
All →Syngene International Management Change
Syngene International Limited announced the resignation of Mr. Pramuch Goel, Head of Corporate Affairs & Communications and Senior Management Personnel, effective September 21, 2026.
Syngene International Other Announcement
Syngene International Limited has issued a communication to shareholders regarding the remittance of the final dividend for the financial year 2025-26.
Syngene International Investor Presentation: Key Takeaways
Syngene reports Q1 FY27 revenue of Rs 736 Cr (-16% YoY). Performance was impacted by low offtake from a major client and forex losses.
Syngene International Earnings Call: Key Takeaways
Syngene FY26 results show muted 3% revenue growth due to 'Librela' destocking headwinds. Management indicates FY27 will be a transition year with flat revenue and mid-20s EBITDA margins.
Syngene International Earnings Call: Key Takeaways
Syngene faces a transition year in FY27 as the Librela de-stocking headwind masks underlying momentum in biologics and research services.
Syngene International Earnings Call: Key Takeaways
Syngene Q4 FY26 revenue grew 2% YoY to Rs 1,037 Cr with 29% EBITDA margin. Full year FY26 revenue reached Rs 3,739 Cr, driven by integrated CRDMO services.